TRANSCODE THERAPEUTICS, INC. Adjustments to Additional Paid in Capital, Warrant Issued
TRANSCODE THERAPEUTICS, INC. (RNAZ) reported Adjustments to Additional Paid in Capital, Warrant Issued of $15.38 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-04-15.
Financial Statements › Shareholders' Equity › Adjustments to Additional Paid in Capital
us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued · last filed 2026-08-14
- TRANSCODE THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2025-03-31 was $15.38M.
- TRANSCODE THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for the quarter ending 2021-09-30 was $64.75K.
- TRANSCODE THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2025 was $15.38M.
- TRANSCODE THERAPEUTICS, INC. adjustments to additional paid in capital, warrant issued for fiscal 2021 was $64.75K.
| Period end | Adjustments to Additional Paid in Capital, Warrant Issued 3 month | Adjustments to Additional Paid in Capital, Warrant Issued 12 month |
|---|---|---|
| 2025-12-31 | $15.38M 10-K · filed 2026-04-15 | |
| 2025-03-31 | $15.38M 10-Q · filed 2026-08-14 | |
| 2021-12-31 | $64.75K 10-K · filed 2022-03-31 | |
| 2021-09-30 | $64.75K 10-Q · filed 2021-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| CHINA PHARMA HOLDINGS, INC. (CPHI) | $0.032B | ||
| AYTU BIOPHARMA, INC (AYTU) | United States | $0.025B | -1.62 |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |